MichaelEWoodsMD

Urology • Maywood, IL

Associate Professor, Surgery, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Woods is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Woods' full profile

Already have an account?

Office
2160 S 1st Ave
Maywood, IL 60153
Phone+1 708-216-9000

Education & Training

Tulane UniversityResidency, Urology, 2002 - 2006
Tulane UniversityInternship, Transitional Year, 2001 - 2002
Loyola University Chicago Stritch School of MedicineClass of 2001

Certifications & Licensure

IL State Medical License 2005 - 2026
FL State Medical License 2020 - 2022
NC State Medical License 2011 - 2022
LA State Medical License 2003 - 2011
American Board of Urology Urology

Clinical Trials

Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
Completed
Not Applicable
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT Start of enrollment: 2013 Dec 01
Terminated
Phase 1, Phase 2
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Terminated

Publications & Presentations

PubMed

90 citations
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer
Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky, Bernard H. Bochner, Guido Dalbagni
Journal of Clinical Oncology. 2018-05-09
2 citations
Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patterns.
Rachel Yang, Goran Rac, Michael D Felice, Gaurav Pahouja, Caitlyn Ko
Journal of Robotic Surgery. 2024-01-12
439 citations
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh, Isildinha M. Reis, Erik P. Castle, Mark L. Gonzalgo, Michael Woods
Lancet. 2018-06-23

Press Mentions

Advanced Bladder Cancers Respond to Immunotherapy Regardless of Gene Mutation StatusJuly 22nd, 2021